NCT03131934
- Conditions
- Post-transplant Lymphoproliferative Disease, Transplant-Related Hematologic Malignancy
- Locations
-
- Great Ormond Street Hospital London, United Kingdom
- King's College Hospital London, United Kingdom
Clinical trial condition
Post-transplant Lymphoproliferative Disease
Explore clinical trials studying Post-transplant Lymphoproliferative Disease. Study availability and eligibility vary by location and protocol.
2 public trials
0 recruiting studies
Post-transplant Lymphoproliferative Disease trial results
Completed
Bortezomib Plus Rituximab for EBV+ PTLD
NCT01058239
- Conditions
- DNA Virus Infections, Epstein Barr Virus Infections, Epstein-Barr Virus Infections, +7 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States